A cost-effectiveness analysis of fluvastatin in patients with diabetes after successful percutaneous coronary intervention

Abstract The Lescol Intervention Prevention Study (LIPS) was a multinational randomized controlled trial that showed a 47% reduction in the relative risk of cardiac death and a 22% reduction in major adverse cardiac events (MACEs) from the routine use of fluvastatin, compared with controls, in patie...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical therapeutics 2005-09, Vol.27 (9), p.1467-1477
Hauptverfasser:	Scuffham, Paul A., Chaplin, Stephen
Format:	Artikel
Sprache:	eng
Schlagworte:	Angioplasty Angioplasty, Balloon, Coronary Biological and medical sciences Cardiovascular disease Cholesterol Coronary vessels Cost analysis Cost-Benefit Analysis cost-effectiveness Diabetes Diabetes Complications - economics Diabetes Complications - prevention & control Diabetes Complications - therapy Diabetes. Impaired glucose tolerance Disease prevention Endocrine pancreas. Apud cells (diseases) Endocrinopathies Etiopathogenesis. Screening. Investigations. Target tissue resistance Fatty Acids, Monounsaturated - economics Fatty Acids, Monounsaturated - therapeutic use Health care Heart heart disease Heart Diseases - economics Heart Diseases - prevention & control Heart Diseases - therapy Hospitals Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors - economics Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use Indoles - economics Indoles - therapeutic use LIPS Markov Chains Medical prognosis Medical sciences Metabolic disorders Models, Economic Monte Carlo simulations Mortality Multicenter Studies as Topic Multivariate Analysis Myocardial infarction Pharmacology. Drug treatments Prevention QALY Quality of life Quality-Adjusted Life Years Randomized Controlled Trials as Topic Risk factors Statins United Kingdom Vein & artery diseases
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!